Redostim

Redostim is a mixture of micronutrients (substances that we must take with food) engineered to strengthen endogenous processes for the synthesis and release of H₂S when and where it is needed. These substances are L-cystine, Taurine and supraphysiologic doses of vitamin B6 (active form, pyridoxal 5 phosphate).

The combined effect of L-cystine, taurine and supraphysiological doses of B6 is an increase in the synthesis of glutathione (GSH) and hydrogen sulfide (H₂S). However, H₂S will be released only where and when it is needed in response to the regulating mechanisms. In other words, Redostim’s combination of micronutrients has the ability to make cells more responsive to H₂S release signals but will not produce any release in the absence of such signals.

A defective release of H₂S has been involved with endothelial dysfunction (i.e. CVD and erectile dysfunction) and hypertension, lung disease and viral infections including those from coronaviruses, male and female infertility and pregnancy disorders, insulin resistance and diabetes, immune function and autoimmune diseases, wound healing and in general to the ageing process (degenerative diseases). Although the ability of Redostim to induce endogenous secretion of H₂S (and GSH) is confirmed there are no proofs of activity in any of the above disease and the product should not be assumed as a treatment for the above.